BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32844038)

  • 1. The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration.
    Levine ES; Custo Greig E; Mendonça LSM; Gulati S; Despotovic IN; Alibhai AY; Moult E; Muakkassa N; Quaranta-El Maftouhi M; El Maftouhi A; Chakravarthy U; Fujimoto JG; Baumal CR; Witkin AJ; Duker JS; Hartnett ME; Waheed NK
    Int J Retina Vitreous; 2020; 6():39. PubMed ID: 32844038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can objective parameters in optical coherence tomography be useful markers in the treatment and follow-up of type 1 and type 2 macular neovascularizations related to neovascular age-related macular degeneration?
    Özen O; Koçak Altıntaş AG
    Int Ophthalmol; 2024 Mar; 44(1):134. PubMed ID: 38483688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration.
    Arrigo A; Aragona E; Di Nunzio C; Bandello F; Parodi MB
    Transl Vis Sci Technol; 2020 Aug; 9(9):48. PubMed ID: 32934898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Analysis of Type 1, 2, and 3 Macular Neovascularization in Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography Shows New Insights into Differences of Pathologic Vasculature and May Lead to a More Personalized Understanding.
    Faatz H; Rothaus K; Ziegler M; Book M; Heimes-Bussmann B; Pauleikhoff D; Lommatzsch A
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETER VARIATIONS AFTER TREATMENT OF MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Parodi MB
    Retina; 2021 Jul; 41(7):1463-1469. PubMed ID: 33315820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-naïve quiescent macular neovascularization secondary to AMD: The 2019 Young Investigator Lecture of Macula Society.
    Querques G; Sacconi R; Capuano V; Carnevali A; Colantuono D; Battista M; Borrelli E; Miere A; Parravano M; Costanzo E; Querques L; Souied EH; Bandello F
    Eur J Ophthalmol; 2021 Nov; 31(6):3164-3176. PubMed ID: 33445977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
    Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
    Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
    [No Abstract]   [Full Text] [Related]  

  • 8. Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography.
    Yanık Ö; Demirel S; Özcan G; Batıoğlu F; Özmert E
    Eye (Lond); 2024 Jun; 38(9):1714-1721. PubMed ID: 38472377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and Functional Relationship Between OCTA and FA/ICGA Quantitative Features in AMD-Related Macular Neovascularization.
    Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Battaglia Parodi M
    Front Med (Lausanne); 2021; 8():758668. PubMed ID: 34746193
    [No Abstract]   [Full Text] [Related]  

  • 10. Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration.
    Corvi F; Cozzi M; Invernizzi A; Pace L; Sadda SR; Staurenghi G
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):291-299. PubMed ID: 32620993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography angiography features of macular neovascularization in wet age-related macular degeneration: A cross-sectional study.
    Ahmed M; Syrine BM; Nadia BA; Anis M; Karim Z; Mohamed G; Hachemi M; Fethi K; Leila K
    Ann Med Surg (Lond); 2021 Oct; 70():102826. PubMed ID: 34540215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization.
    Costanzo E; Parravano M; Giannini D; Borrelli E; Sacconi R; Querques G
    Transl Vis Sci Technol; 2021 May; 10(6):18. PubMed ID: 34111264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Angiography Quantitative Assessment of Macular Neovascularization in Best Vitelliform Macular Dystrophy.
    Parodi MB; Arrigo A; Bandello F
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):61. PubMed ID: 32602906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD.
    Faatz H; Rothaus K; Ziegler M; Book M; Spital G; Lange C; Lommatzsch A
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
    Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography.
    Jia H; Lu B; Zhao Z; Yu Y; Wang F; Zhou M; Sun X
    Eye Vis (Lond); 2022 May; 9(1):16. PubMed ID: 35505390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
    Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
    BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognizing Atrophy and Mixed-Type Neovascularization in Age-Related Macular Degeneration Via Clinicopathologic Correlation.
    Chen L; Li M; Messinger JD; Ferrara D; Curcio CA; Freund KB
    Transl Vis Sci Technol; 2020 Jul; 9(8):8. PubMed ID: 32855855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projection artifact removal improves visualization and quantitation of macular neovascularization imaged by optical coherence tomography angiography.
    Zhang Q; Zhang A; Lee CS; Lee AY; Rezaei KA; Roisman L; Miller A; Zheng F; Gregori G; Durbin MK; An L; Stetson PF; Rosenfeld PJ; Wang RK
    Ophthalmol Retina; 2017; 1(2):124-136. PubMed ID: 28584883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.